Richard J Deane

Is RAGE still a therapeutic target for Alzheimer's disease?

Richard J Deane, 2012, Future medicinal chemistry.

Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance

R. Deane, R. Bell, R. Gelein, 2013, Proceedings of the National Academy of Sciences.

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Nathan T. Ross, A. E. Friedman, R. Deane, 2012, The Journal of clinical investigation.

Radiofrequency ablation of bone with cooled probes and impedance control energy delivery in a pig model: MR imaging features.

S. Eustace, C. Cantwell, P. Dervan, 2007, Journal of vascular and interventional radiology : JVIR.

Is RAGE still a therapeutic target for Alzheimer's disease?

Richard J Deane, 2012, Future medicinal chemistry.